[
  {
    "text": "1.\n              Princiotta MF, Finzi D, Qian S-B, Gibbs J, Schuchmann S, et al. (2003) Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343\u201354.\n        doi:\n        10.1016/S1074-7613(03)00051-7.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "2.\n              Boisvert F-M, Ahmad Y, Gierlinski M, Charri\u00e8re F, Lamont D, et al. (2011) A quantitative spatial proteomics analysis of proteome turnover in human cells. Mol Cell Proteomics 11 (3) \nM111.011429.\n        doi:\n        10.1074/mcp.M111.011429.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "3.\n              Cambridge SB, Gnad F, Nguyen C, Bermejo JL, Kr\u00fcger M, et al. (2011) Systems-wide proteomic analysis in mammalian cells reveals conserved, functional protein turnover. J Proteome Res 10: 5275\u201384.\n        doi:\n        10.1021/pr101183k.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "4.\n              Schwanh\u00e4usser B, Busse D, Li N, Dittmar G, Schuchhardt J, et al. (2011) Global quantification of mammalian gene expression control. Nature 473: 337\u201342.\n        doi:\n        10.1038/nature11848.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "5.\n              Savas JN, Toyama BH, Xu T, Yates JR, Hetzer MW (2012) Extremely long-lived nuclear pore proteins in the rat brain. Science 335 (6071) \n942.\n        doi:\n        10.1126/science.1217421.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "6.\n              Yen H-CS, Xu Q, Chou DM, Zhao Z, Elledge SJ (2008) Global protein stability profiling in mammalian cells. Science 322 (5903) \n918\u201323.\n        doi:\n        10.1126/science.1160489.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "7.\n              Price JC, Guan S, Burlingame A, Prusiner SB, Ghaemmaghami S (2010) Analysis of proteome dynamics in the mouse brain. Proc Natl Acad Sci U S A 107 (32) \n14508\u201313.\n        doi:\n        10.1073/pnas.1006551107.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "8.\n              Ciechanover A, Schwartz AL (2002) Ubiquitin-mediated degradation of cellular proteins in health and disease. Hepatology 35 (1) \n3\u20136.\n        doi:\n        10.1053/jhep.2002.30316.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "9.\n              Nakayama KI, Nakayama K (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 6 (5) \n369\u201381.\n        doi:\n        10.1038/nrc1881.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "10.\n              Maltzman W, Czyzyk L (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4 (9) \n1689\u201394. \n                      Find this article online\n                    "
  }, 
  {
    "text": "11.\n              Reihsaus E, Kohler M, Kraiss S, Oren M, Montenarh M (1990) Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells. Oncogene 5 (1) \n137\u201345. \n                      Find this article online\n                    "
  }, 
  {
    "text": "12.\n              O'Dea EL, Barken D, Peralta RQ, Tran KT, Werner SL, et al. (2007) A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol Syst Biol 3: 111.\n        doi:\n        10.1038/msb4100148.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "13.\n              O'Dea EL, Kearns JD, Hoffmann A (2008) UV as an amplifier rather than inducer of NF-kappaB activity. Mol Cell 30 (5) \n632\u201341.\n        doi:\n        10.1016/j.molcel.2008.03.017.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "14.\n              Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ, et al. (2000) Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci U S A 97 (21) \n11250\u20135.\n        doi:\n        10.1073/pnas.210171597.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "15.\n              Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, et al. (2004) Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 36 (2) \n147\u201350.\n        doi:\n        10.1038/ng1293.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "16.\n              Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, et al. (2006) Oscillations and variability in the p53 system. Mol Syst Biol 2: 2006.0033.\n        doi:\n        10.1038/msb4100068.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "17.\n              Batchelor E, Mock CS, Bhan I, Loewer A, Lahav G (2008) Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Mol Cell 30 (3) \n277\u201389.\n        doi:\n        10.1016/j.molcel.2008.03.016.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "18.\n              Batchelor E, Loewer A, Lahav G (2009) The ups and downs of p53: understanding protein dynamics in single cells. Nat Rev Cancer 9 (5) \n371\u20137.\n        doi:\n        10.1038/nrc2604.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "19.\n              Iwamoto K, Hamada H, Okamoto M (2011) Mechanism of cell cycle disruption by multiple p53 pulses. Genome inform 25 (1) \n12\u201324. \n                      Find this article online\n                    "
  }, 
  {
    "text": "20.\n              Zhang X-P, Liu F, Wang W (2011) Two-phase dynamics of p53 in the DNA damage response. Proc Natl Acad Sci U S A 108 (22) \n8990\u20135.\n        doi:\n        10.1073/pnas.1100600108.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "21.\n              Purvis JE, Karhohs KW, Mock C, Batchelor E, Loewer A, et al. (2012) p53 dynamics control cell fate. Science 336 (6087) \n1440\u20134.\n        doi:\n        10.1126/science.1218351.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "22.\n              Hoffmann A, Baltimore D (2006) Circuitry of nuclear factor kappaB signaling. Immunol Ref 210: 171\u201386.\n        doi:\n        10.1111/j.0105-2896.2006.00375.x.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "23.\n              Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132 (3) \n344\u201362.\n        doi:\n        10.1016/j.cell.2008.01.020.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "24.\n              O'Dea E, Hoffmann A (2009) NF-kappaB signaling. Wiley Interdiscip Rev Syst Biol Med 1 (1) \n107\u201315.\n        doi:\n        10.1002/wsbm.30.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "25.\n              Mathes E, O'Dea EL, Hoffmann A, Ghosh G (2008) NF-kappaB dictates the degradation pathway of IkappaBalpha. EMBO J 27 (9) \n1357\u201367. \n                      Find this article online\n                    "
  }, 
  {
    "text": "26.\n              Mathes E, Wang L, Komives E, Ghosh G (2010) Flexible regions within IkappaBalpha create the ubiquitin-independent degradation signal. J Biol Chem 285 (43) \n32927\u201336. \n                      Find this article online\n                    "
  }, 
  {
    "text": "27.\n              Stommel JM, Wahl GM (2004) Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. EMBO J 23 (7) \n1547\u201356.\n        doi:\n        10.1038/sj.emboj.7600145.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "28.\n              Tam AB, Mercado EL, Hoffmann A, Niwa M (2012). ER Stress Activates NF-kappaB by Integrating Functions of Basal IKK Activity, IRE1 and PERK. PloS One 7: , e45078. "
  }, 
  {
    "text": "29.\n              Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002) The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298 (5596) \n1241\u20135. \n                      Find this article online\n                    "
  }, 
  {
    "text": "30.\n              Werner SL, Barken D, Hoffmann A (2005) Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309 (5742) \n1857\u201361.\n        doi:\n        10.1126/science.1113319.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "31.\n              Gu J, Kawai H, Nie L, Kitao H, Wiederschain D, et al. (2002) Mutual dependence of MDM2 and MDMX in their functional inactivation of p53. J Biol Chem 277 (22) \n19251\u20134.\n        doi:\n        10.1074/jbc.C200150200.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "32.\n              Xiong L, Kou F, Yang Y, Wu J (2007) A novel role for IGF-1R in p53-mediated apoptosis through translational modulation of the p53-Mdm2 feedback loop. J Cell Biol 178 (6) \n995\u20131007.\n        doi:\n        10.1083/jcb.200703044.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "33.\n              Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, et al. (1990) p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 87 (19) \n7555\u20139.\n        doi:\n        10.1073/pnas.87.19.7555.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "34.\n              Midgley CA, Lane DP (1997) p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15 (10) \n1179\u201389.\n        doi:\n        10.1038/sj.onc.1201459.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "35.\n              Nakamura S, Roth JA, Mukhopadhyay T (2000) Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination. Mol Cell Biol 20 (24) \n9391\u20138.\n        doi:\n        10.1128/MCB.20.24.9391-9398.2000.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "36.\n              Kern SE, Kinzler KW, Baker SJ, Nigro JM, Rotter V, et al. (1991) Mutant p53 proteins bind DNA abnormally in vitro. Oncogene 6 (1) \n131\u20136. \n                      Find this article online\n                    "
  }, 
  {
    "text": "37.\n              Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, et al. (1992) Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256 (5058) \n827\u201330.\n        doi:\n        10.1126/science.1589764.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "38.\n              Pavletich NP, Chambers KA, Pabo CO (1993) The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 7 (12B) \n2556\u201364.\n        doi:\n        10.1101/gad.7.12b.2556.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "39.\n              Cho Y, Gorina S, Jeffrey PD, Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265 (5170) \n346\u201355.\n        doi:\n        10.1126/science.8023157.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "40.\n              Gudkov AV, Komarova EA (2003) The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 3 (2) \n117\u201329.\n        doi:\n        10.1038/nrc992.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "41.\n              Lee JM, Bernstein A (1993) P53 Mutations Increase Resistance To Ionizing Radiation. Proc Natl Acad Sci U S A 90 (12) \n5742\u20136.\n        doi:\n        10.1073/pnas.90.12.5742.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "42.\n              Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, et al. (1994) p53 status and the efficacy of cancer therapy in vivo. Science 266 (5186) \n807\u201310.\n        doi:\n        10.1126/science.7973635.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "43.\n              Wallace-Brodeur RR, Lowe SW (1999) Clinical implications of p53 mutations. Cell Mol Life Sci 55 (1) \n64\u201375. \n                      Find this article online\n                    "
  }, 
  {
    "text": "44.\n              Rogel A, Popliker M, Webb CG, Oren M (1985) p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 5 (10) \n2851\u20135. \n                      Find this article online\n                    "
  }, 
  {
    "text": "45.\n              Komarova EA, Chernov MV, Franks R, Wang K, Armin G, et al. (1997) Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J 16 (6) \n1391\u2013400. \n                      Find this article online\n                    "
  }, 
  {
    "text": "46.\n              Komarova EA, Christov K, Faerman AI, Gudkov AV (2000) Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene 19 (33) \n3791\u20138.\n        doi:\n        10.1038/sj.onc.1203717.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "47.\n              Pan Y, Haines DS (1999) The pathway regulating MDM2 protein degradation can be altered in human leukemic cells. Cancer Res 59 (9) \n2064\u20137. \n                      Find this article online\n                    "
  }, 
  {
    "text": "48.\n              Mendrysa SM, McElwee MK, Michalowski J, O'Leary KA, Young KM, et al. (2003) mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation. Mol Cell Biol 23 (2) \n462\u201372.\n        doi:\n        10.1128/MCB.23.2.462-473.2003.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "49.\n              Perry ME (2004) Mdm2 in the response to radiation. Mol Cancer Res 2 (1) \n9\u201319. \n                      Find this article online\n                    "
  }, 
  {
    "text": "50.\n              Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, et al. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281 (5383) \n1674\u20137.\n        doi:\n        10.1126/science.281.5383.1674.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "51.\n              Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, et al. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281 (5383) \n1677\u20139.\n        doi:\n        10.1126/science.281.5383.1677.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "52.\n              Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (6922) \n499\u2013506.\n        doi:\n        10.1038/nature01368.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "53.\n              Ma L, Wagner J, Rice JJ, Hu W, Levine AJ, et al. (2005) A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci U S A 102 (40) \n14266\u201371.\n        doi:\n        10.1073/pnas.0501352102.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "54.\n              Buscemi G, Perego P, Carenini N, Nakanishi M, Chessa L, et al. (2004) Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene 23 (46) \n7691\u2013700.\n        doi:\n        10.1038/sj.onc.1207986.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "55.\n              Becker V, Schilling M, Bachmann J, Baumann U, Raue A, et al. (2010) Covering a broad dynamic range: information processing at the erythropoietin receptor. Science 328 (5984) \n1404\u20138.\n        doi:\n        10.1126/science.1184913.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "56.\n              Lee T, Yao G, Nevins J, You L (2008) Sensing and integration of Erk and PI3K signals by Myc. PLoS Comput Biol 4: e1000013.\n        doi:\n        10.1371/journal.pcbi.1000013.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "57.\n              McKeithan TW (1995) Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A 92 (11) \n5042\u20136.\n        doi:\n        10.1073/pnas.92.11.5042.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "58.\n              Groban ES, Clarke EJ, Salis HM, Miller SM, Voigt C a (2009) Kinetic buffering of cross talk between bacterial two-component sensors. J Mol Biol 390 (3) \n380\u201393.\n        doi:\n        10.1016/j.jmb.2009.05.007.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "59.\n              Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D (1988) P53 expression in breast cancer. Int J Cancer 41 (2) \n178\u201383.\n        doi:\n        10.1002/ijc.2910410204.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "60.\n              Ostrowski JL, Sawan A, Henry L, Wright C, Henry J a, et al. (1991) p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study. J Pathol 164 (1) \n75\u201381.\n        doi:\n        10.1002/path.1711640113.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "61.\n              Isola J, Visakorpi T, Holli K, Kallioniemi OP (1992) Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84 (14) \n1109\u201314. \n                      Find this article online\n                    "
  }, 
  {
    "text": "62.\n              Martin HM, Filipe MI, Morris RW, Lane DP, Silvestre F (1992) p53 expression and prognosis in gastric carcinoma. Int J Cancer 50 (6) \n859\u201362.\n        doi:\n        10.1002/ijc.2910500604.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "63.\n              Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM (1992) Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52 (17) \n4828\u201331. \n                      Find this article online\n                    "
  }, 
  {
    "text": "64.\n              Yamaguchi A, Kurosaka Y, Fushida S, Kanno M, Yonemura Y, et al. (1992) Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 70 (12) \n2778\u201384.\n        doi:\n        <2778::AID-CNCR2820701209&gt;3.0.CO;2-L\">10.1002/1097-0142(19921215)70:12&lt;2778::AID-CNCR2820701209&gt;3.0.CO;2-L.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "65.\n              Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, et al. (1995) Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. Cancer Res 55 (21) \n5038\u201342. \n                      Find this article online\n                    "
  }, 
  {
    "text": "66.\n              Sohda M, Ishikawa H, Masuda N, Kato H, Miyazaki T, et al. (2004) Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer. Int J Cancer 110 (6) \n838\u201344. \n                      Find this article online\n                    "
  }, 
  {
    "text": "67.\n              Lessard L, Mes-Masson A-M, Lamarre L, Wall L, Lattouf J-B, et al. (2003) NF-kappa B nuclear localization and its prognostic significance in prostate cancer. BJU Int 91 (4) \n417\u201320. \n                      Find this article online\n                    "
  }, 
  {
    "text": "68.\n              Lessard L, Karakiewicz PI, Bellon-Gagnon P, Alam-Fahmy M, Ismail HA, et al. (2006) Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Clin Cancer Res 12 (19) \n5741\u20135. \n                      Find this article online\n                    "
  }, 
  {
    "text": "69.\n              Wynford-Thomas D (1992) P53 in tumour pathology: can we trust immunocytochemistry? J Pathol 166 (4) \n329\u201330.\n        doi:\n        10.1002/path.1711660402.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "70.\n              Izzo JG, Malhotra U, Wu T-T, Ensor J, Luthra R, et al. (2006) Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol 24 (5) \n748\u201354. \n                      Find this article online\n                    "
  }, 
  {
    "text": "71.\n              Hawkins DS, Demers GW, Galloway DA (1996) Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 56 (4) \n892\u20138. \n                      Find this article online\n                    "
  }, 
  {
    "text": "72.\n              Henson DE (1996) Loss of p53-immunostaining intensity in breast cancer. J Natl Cancer Inst 88 (15) \n1015\u20136.\n        doi:\n        10.1093/jnci/88.15.1015.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "73.\n              Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ (1996) Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 88 (15) \n1054\u20139.\n        doi:\n        10.1093/jnci/88.15.1054.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "74.\n              Eid H, Van der Looij M, Institoris E, G\u00e9czi L, Bodrogi I, et al. (1997) Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer? Anticancer Res 17 (4A) \n2663\u20139. \n                      Find this article online\n                    "
  }, 
  {
    "text": "75.\n              Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, et al. (2002) Network motifs: simple building blocks of complex networks. Science 298 (5594) \n824\u20137.\n        doi:\n        10.1126/science.298.5594.824.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "76.\n              Alon U (2007) Network motifs: theory and experimental approaches. Nat Rev Genet 8 (6) \n450\u201361.\n        doi:\n        10.1038/nrg2102.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "77.\n              Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89 (12) \n5547\u201351.\n        doi:\n        10.1073/pnas.89.12.5547.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "78.\n              Gossen M, Freundlieb S, Bender G, M\u00fcller G, Hillen W, et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268 (5218) \n1766\u20139.\n        doi:\n        10.1126/science.7792603.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "79.\n              Grilly C, Stricker J, Pang WL, Bennett MR, Hasty J (2007) A synthetic gene network for tuning protein degradation in Saccharomyces cerevisiae. Mol Syst Biol 3: 127.\n        doi:\n        10.1038/msb4100168.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "80.\n              Rondelez Y (2012) Competition for catalytic resources alters biological network dynamics. Phys Rev Lett 108 (1) \n018102.\n        doi:\n        10.1103/PhysRevLett.108.018102.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "81.\n              Grima R, Schnell S (2008) Modelling reaction kinetics inside cells. Essays Biochem 45: 41\u201356.\n        doi:\n        10.1042/BSE0450041.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "82.\n              Sreenath SN, Cho K-H, Wellstead P (2008) Modelling the dynamics of signalling pathways. Essays Biochem 45: 1\u201328.\n        doi:\n        10.1042/BSE0450001.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "83.\n              Sauro HM (2009) Network Dynamics. In: Ireton R, Montgomery K, Bumgarner R, Samudrala R, McDermott J, editors. Computational Systems Biology. Volume 541. New York:Humana Press. pp. 269\u2013309. "
  }, 
  {
    "text": "84.\n              MacDonald N (1977) Time lag in a model of a biochemical reaction sequence with end product inhibition. J Theor Biol 67 (3) \n549\u201356.\n        doi:\n        10.1016/0022-5193(77)90056-X.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "85.\n              Mather W, Bennett MR, Hasty J, Tsimring LS (2009) Delay-induced degrade-and-fire oscillations in small genetic circuits. Phys Rev Lett 102 (6) \n068105.\n        doi:\n        10.1103/PhysRevLett.102.068105.\n       \n                      Find this article online\n                    "
  }, 
  {
    "text": "86.\n              Shih VF-S, Kearns JD, Basak S, Savinova OV, Ghosh G, et al. (2009) Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity. Proc Natl Acad Sci U S A 106 (24) \n9619\u201324. \n                      Find this article online\n                    "
  }
]